Halozyme Therapeutics shares are trading lower after the company reported mixed Q4 financial results.
Halozyme Therapeutics, Inc. +0.24%
Halozyme Therapeutics, Inc. HALO | 67.47 | +0.24% |
Halozyme Therapeutics shares are trading lower after the company reported mixed Q4 financial results.
